GI
AZN icon

GAMMA Investing’s AstraZeneca AZN Stock Holding History

GAMMA Investing’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.12M Sell
6,941
-550
-7% -$91.7K 0.04% 388
2026
Q2 		$1.42M Sell
7,491
-147
-2% -$27.6K 0.05% 297
2026
Q1 		$1.51M Buy
7,638
+997
+15% +$192K 0.07% 242
2025
Q4 		$1.22M Buy
6,641
+1,023
+18% +$179K 0.06% 250
2025
Q3 		$862K Buy
5,618
+1,156
+26% +$175K 0.05% 335
2025
Q2 		$624K Buy
4,462
+523
+13% +$73.3K 0.04% 405
2025
Q1 		$579K Buy
3,939
+1,190
+43% +$172K 0.04% 369
2024
Q4 		$360K Buy
2,749
+32
+1% +$4.48K 0.03% 476
2024
Q3 		$423K Buy
2,717
+444
+20% +$71.7K 0.04% 376
2024
Q2 		$355K Buy
2,273
+493
+28% +$74.2K 0.05% 343
2024
Q1 		$241K Buy
1,780
+310
+21% +$41K 0.05% 340
2023
Q4 		$196K Buy
+1,470
New +$191K 0.05% 309

Other funds holding AZN

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
PAS
Professional Advisory Services Vero Beach, Florida $837M AUM 20.44% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7B AUM 14.85% 1-Year Est. Return
PNC
Park National Corp Newark, Ohio $3.69B AUM 18.32% 1-Year Est. Return
CCM
Cox Capital Management Andover, Massachusetts $179M AUM 28.94% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
CNBT
Canandaigua National Bank & Trust Canandaigua, New York $1.15B AUM
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
PC
Parrish Capital Kennesaw, Georgia $103M AUM 35.11% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return

GAMMA Investing's AZN Position: Q3 2026 in Review

GAMMA Investing reduced its AstraZeneca (AZN) stake by 7.3% in Q3 2026, selling an estimated $91.7K and leaving 6,941 shares worth $1.12M. The position accounts for 0.04% of the portfolio, ranked #388.

GAMMA Investing first reported a position in AZN in Q4 2023 and has held it in 12 quarters since. The position peaked at $1.51M in Q1 2026. 47 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • GAMMA Investing held 6,941 shares of AstraZeneca worth $1.12M as of Q3 2026.
  • GAMMA Investing sold 550 AstraZeneca shares in Q3 2026, an estimated $91.7K.
  • AstraZeneca made up 0.04% of GAMMA Investing's portfolio in Q3 2026, its #388 holding.
  • GAMMA Investing first reported a position in AstraZeneca in Q4 2023 and has held it in 12 quarters since.
  • GAMMA Investing's AstraZeneca position peaked at $1.51M in Q1 2026.
  • 47 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.